Suppr超能文献

野生型和变异型丙型肝炎病毒肽与CD4 T细胞的结合会调节病毒清除辅助性T细胞向调节性T细胞的转化。

CD4 T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs.

作者信息

Cusick Matthew F, Libbey Jane E, Cox Gill Joan, Fujinami Robert S, Eckels David D

机构信息

Department of Pathology, University of Utah School of Medicine, 30 North 1900 East, 3R330 SOM, Salt Lake City, UT 84132, USA.

Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53226, USA.

出版信息

Future Virol. 2013 Jul;8(7). doi: 10.2217/fvl.13.49.

Abstract

AIM

To determine whether modulation of T-cell responses by naturally occurring viral variants caused an increase in numbers of Tregs in HCV-infected patients.

PATIENTS MATERIALS & METHODS: Human peripheral blood mononuclear cells, having proliferative responses to a wild-type HCV-specific CD4 T-cell epitope, were used to quantify, via proliferative assays, flow cytometry and class II tetramers, the effects of naturally occurring viral variants arising in the immunodominant epitope.

RESULTS

In combination, the wild-type and variant peptides led to enhanced suppression of an anti-HCV T-cell response. The variant had a lower avidity for the wild-type-specific CD4 T cell. Variant-stimulated CD4 T cells had increased Foxp3, compared with wild-type-stimulated cells.

CONCLUSION

A stable viral variant from a chronic HCV subject was able to induce Tregs in multiple individuals that responded to the wild-type HCV-specific CD4 T-cell epitope.

摘要

目的

确定天然存在的病毒变异体对T细胞反应的调节是否会导致丙型肝炎病毒(HCV)感染患者中调节性T细胞(Tregs)数量增加。

患者材料与方法

使用对野生型HCV特异性CD4 T细胞表位具有增殖反应的人外周血单个核细胞,通过增殖试验、流式细胞术和II类四聚体来量化免疫显性表位中天然存在的病毒变异体的影响。

结果

野生型和变异体肽共同作用导致抗HCV T细胞反应的抑制增强。变异体对野生型特异性CD4 T细胞的亲和力较低。与野生型刺激的细胞相比,变异体刺激的CD4 T细胞中Foxp3增加。

结论

来自慢性HCV患者的稳定病毒变异体能够在多个对野生型HCV特异性CD4 T细胞表位有反应的个体中诱导Tregs。

相似文献

3
Increased peripheral CD4 regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C.
J Hepatol. 2017 May;66(5):888-896. doi: 10.1016/j.jhep.2016.12.019. Epub 2016 Dec 29.
4
Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
Immunol Cell Biol. 2007 Apr-May;85(3):197-204. doi: 10.1038/sj.icb.7100020. Epub 2007 Jan 2.
5
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
PLoS One. 2017 Jan 23;12(1):e0170516. doi: 10.1371/journal.pone.0170516. eCollection 2017.
7
Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.
World J Gastroenterol. 2010 Apr 28;16(16):1953-69. doi: 10.3748/wjg.v16.i16.1953.
8
HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients.
J Hepatol. 2015 Jan;62(1):48-55. doi: 10.1016/j.jhep.2014.08.026. Epub 2014 Aug 23.

引用本文的文献

1
Targeting regulatory T cells to improve vaccine immunogenicity in early life.
Front Microbiol. 2014 Sep 11;5:477. doi: 10.3389/fmicb.2014.00477. eCollection 2014.

本文引用的文献

1
Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function.
Hum Immunol. 2012 Mar;73(3):232-9. doi: 10.1016/j.humimm.2011.12.012. Epub 2011 Dec 27.
4
Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses.
Clin Dev Immunol. 2011;2011:806061. doi: 10.1155/2011/806061. Epub 2010 Dec 6.
5
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
J Exp Med. 2010 Aug 2;207(8):1701-11. doi: 10.1084/jem.20091999. Epub 2010 Jul 26.
7
Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.
J Gen Virol. 2010 Jun;91(Pt 6):1396-406. doi: 10.1099/vir.0.017699-0. Epub 2010 Jan 27.
9
Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
J Immunol. 2009 Oct 15;183(8):4895-903. doi: 10.4049/jimmunol.0901459.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验